Search Results - Yanhua Hu
- Showing 1 - 1 results of 1
-
1
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial by Ian M. Catlett, Lu Gao, Yanhua Hu, Subhashis Banerjee, James G. Krueger
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book